| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| GRAL | GRAIL, Inc. | Director | $2.76M | Oct 15, 2025 | ||
| NTLA | Intellia Therapeutics, Inc. | Director | $1.35M | +$1M | +288% | Aug 20, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|